Modulation of the sepsis inflammatory response by resuscitation: The missing link between cytopathic and hypoxic hypoxia?

Critical Care Medicine

Volumn 35, Issue 9, 2007, Pages 2206-2207

  Trzeciak, Stephen ^a   De Backer, Daniel ^b  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Biomarkers; Hemodynamics; Microcirculation; Organ failure; Sepsis; Septic shock; Severe sepsis; Tissue perfusion

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; DOBUTAMINE; TUMOR NECROSIS FACTOR;

ARTERIAL PRESSURE; BLOOD VESSEL TONE; CYTOPATHOGENIC EFFECT; DISEASE DURATION; DISEASE SEVERITY; EDITORIAL; HEART ARREST; HEART OUTPUT; HEMODYNAMICS; HISTORY; HUMAN; HYPOTENSION; HYPOXIA; IN VITRO STUDY; INFLAMMATION; MICROVASCULARIZATION; MORTALITY; NONHUMAN; ORGAN INJURY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESUSCITATION; SEPSIS; SEPTIC SHOCK; THERAPY EFFECT;

ANOXIA; CELL HYPOXIA; CYTOKINES; HUMANS; INFLAMMATION; RESUSCITATION; SEPSIS; SHOCK, SEPTIC;

EID: 34548291976     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000281639.42926.00     Document Type: Editorial

References (27)

1. Dinarello CA, Cannon JG, Wolff SM, et al: Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163:1433-1450
2. Waage A, Espevik T, Lamvik J: Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scand J Immunol 1986; 24:739-743
3. Waage A, Brandtzaeg P, Halstensen A, et al: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169:333-338
4. Suffredini AF, Fromm RE, Parker MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-287
5. van Deventer SJ, Buller HR, ten Cate JW, et al: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76:2520-2526
6. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778
7. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103:565-575
8. Russell JA: Management of sepsis. N Engl J Med 2006; 355:1699-1713
9. Rivers EP, Kruse JA, Jacobsen G: The influence of early hemodynamic optimization strategies on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007; 35:2016-2024
10. Varpula M, Tallgren M, Saukkonen K, et al: Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005; 31:1066-1071
11. Sakr Y, Dubois MJ, De Backer D, et al: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-1831
12. Lin SM, Huang CD, Lin HC, et al: A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: A randomized controlled trial. Shock 2006; 26:551-557
13. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
14. 2 Collaborative Group. N Engl J Med 1995; 333:1025-1032
15. Hotchkiss RS, Swanson PE, Freeman BD, et al: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251
16. Natanson C, Eichenholz PW, Danner RL, et al: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823-832
17. Nakamura M, Shibazaki M, Nitta Y, et al: Translocation of platelets into Disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1, and tumour necrosis factor: The role of Kupffer cells. J Hepatol 1998; 28:991-999
18. Vicaut E, Hou X, Payen D, et al: Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle. J Clin Invest 1991; 87:1537-1540
19. De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166:98-104
20. Trzeciak S, Dellinger RP, Parrillo JE, et al: Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: Relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007; 49:88-98.e2
21. Rose J, Martin C: Tissue bioenergetics and microvascular perfusion are impaired in rat ileal mucosa in normotensive sepsis. Microcirculation 2006; 13:49-56
22. De Backer D, Creteur J, Dubois MJ, et al: The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006; 34:403-408
23. Zingarelli B, Squadrito F, Altavilla D, et al: Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. Am J Physiol 1994; 266(4 Pt 2):H1512-H1515
24. Schoots IG, Levi M, van Vliet AK, et al: Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats. Crit Care Med 2004; 32:1375-1383
25. Bateman RM, Tokunaga C, Kareco T, et al: Myocardial hypoxia-inducible HIF-1α, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia. Am J Physiol Heart Circ Physiol 2007; 293:H448-H456
26. Adrie C, Laurent I, Monchi M, et al: Postresuscitation disease after cardiac arrest: A sepsis-like syndrome? Curr Opin Crit Care 2004; 10:208-212
27. Tamura DY, Moore EE, Partrick DA, et al: Acute hypoxemia in humans enhances the neutrophil inflammatory response. Shock 2002; 17:269-273